Laboratory Corporation of America Holdings /
BioReference Health, LLC
OPKO unit agrees to sell lab testing assets to LabCorp
Source for the buyer and target: OPKO Health, Inc.
For the buyer and target.
“On October 14, 2026, OPKO Health, Inc., a Delaware corporation (“ OPKO ”), its wholly owned subsidiary, BioReference Health, LLC (“ BioReference ” and together with OPKO, “ Seller ”), and Laboratory Corporation of America Holdings, a Delaware corporation (“ Buyer ”), entered into an Asset Purchase Agreement (the “ Purchase Agreement ”).”
Published 15 Oct 2026
Open the sourceWhat happened
BioReference Health, a subsidiary of OPKO Health, agreed to sell assets of its clinical and anatomic pathology testing business to Laboratory Corporation of America Holdings under an Asset Purchase Agreement dated Oct. 14, 2026. The assets include women's health and urology testing and the 4Kscore prostate cancer test. [01]
The buyer agreed to pay $722,000,000 in cash at closing, subject to adjustments tied to Business revenues, plus up to $150,000,000 in additional cash over up to ten years based on 4Kscore sales. Closing depends on customary conditions, including HSR clearance, and is not subject to a financing condition. [01]
The source
Everything on this page comes from the source below, quoted word for word.
OPKO unit agrees to sell lab testing assets to LabCorp
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“OPKO unit agrees to sell lab testing assets to LabCorp BioReference Health, a subsidiary of OPKO Health, agreed to sell assets of its clinical and anatomic pathology testing business to Laboratory Corporation of Ameri…”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
Deal Web
Every firm and person on this deal, and how they connect. Open any name to see their other deals.
Agreement signed · Laboratory Corporation of America Holdings / BioReference Health, LLC deal (Agreement signed, published 15 Oct 2026).
Announced 14 Oct 2026- Announced
- Published by OPKO Health, Inc.
Deal Web as a list
- Laboratory Corporation of America Holdings (Buyer) buyer this deal. Laboratory Corporation of America Holdings: 1 deal on Carrywatch.
- BioReference Health, LLC (Target) target this deal. BioReference Health, LLC: 1 deal on Carrywatch.
By email · Weekly